Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
Rheumatoid arthritis (RA) is a chronic systemic autoimmune condition which affects approximately 1% of the adult population worldwide and is characterized by joint inflammation, with extra-articular features being common. Interleukin 6 (IL-6) is one of the chief pro-inflammatory cytokines found in t...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Healthcare
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883250/ |